<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="uk">
		<id>http://istoriya.soippo.edu.ua/index.php?action=history&amp;feed=atom&amp;title=NVP-BGJ398_Available_for_The_beginner</id>
		<title>NVP-BGJ398 Available for The beginner - Історія редагувань</title>
		<link rel="self" type="application/atom+xml" href="http://istoriya.soippo.edu.ua/index.php?action=history&amp;feed=atom&amp;title=NVP-BGJ398_Available_for_The_beginner"/>
		<link rel="alternate" type="text/html" href="http://istoriya.soippo.edu.ua/index.php?title=NVP-BGJ398_Available_for_The_beginner&amp;action=history"/>
		<updated>2026-05-04T02:59:33Z</updated>
		<subtitle>Історія редагувань цієї сторінки в вікі</subtitle>
		<generator>MediaWiki 1.24.1</generator>

	<entry>
		<id>http://istoriya.soippo.edu.ua/index.php?title=NVP-BGJ398_Available_for_The_beginner&amp;diff=195344&amp;oldid=prev</id>
		<title>Drawer9parade: Створена сторінка: Compared with TTP, cases with malignant hypertension-induced TMA are shown to have higher blood pressure at presentation, signs of hypertensive heart disease [v...</title>
		<link rel="alternate" type="text/html" href="http://istoriya.soippo.edu.ua/index.php?title=NVP-BGJ398_Available_for_The_beginner&amp;diff=195344&amp;oldid=prev"/>
				<updated>2017-06-28T11:14:29Z</updated>
		
		<summary type="html">&lt;p&gt;Створена сторінка: Compared with TTP, cases with malignant hypertension-induced TMA are shown to have higher blood pressure at presentation, signs of hypertensive heart disease [v...&lt;/p&gt;
&lt;p&gt;&lt;b&gt;Нова сторінка&lt;/b&gt;&lt;/p&gt;&lt;div&gt;Compared with TTP, cases with malignant hypertension-induced TMA are shown to have higher blood pressure at presentation, signs of hypertensive heart disease [van den Born et al.  2005] or retinopathy, higher platelet count [Shibagaki and Fujita, 2005; Shavit et al. 2010] and higher ADAMTS-13 activity [van den Born et al. 2008]. Patients with malignant hypertension, compared with healthy controls, can have lower levels of ADAMTS-13; the levels negatively correlated with LDH levels, platelet count and the presence of schistocytes. However, the deficiency of ADAMTS-13 is always mild (activity &amp;gt;50%) [van den Born et al. 2008]. In the Oklahoma TTP Registry, none of the patients with malignant hypertension-induced TMA had ADAMTS-13 activity  failure. Aggressive management of blood pressure in malignant hypertension-induced TMA has been previously shown to result in resolution of TMA  and gradual return of renal function [Zhang et al. 2008]. Although high creatinine levels and systolic hypertension at presentation are associated with a lower chance of renal recovery [van den Born et al. 2005], malignant hypertension patients ultimately may have more favorable nonrenal [http://www.selleckchem.com/products/Romidepsin-FK228.html FK228 cost] prognosis than other thrombotic microangiopathies [Zhang et al. 2008]. Conclusion In conclusion, prior history of hypertension, high mean arterial pressure, significant renal impairment but relatively modest  thrombocytopenia and lack of severe ADAMTS-13 deficiency (activity&lt;/div&gt;</summary>
		<author><name>Drawer9parade</name></author>	</entry>

	</feed>